Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ezetimibe as a Safe and Efficacious Treatment for Chronic Hepatitis C

NCT02971033 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT02971033
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02971033 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ezetimibe as a Safe and Efficacious Treatment for Chronic Hepatitis C
Lead sponsor
VA Office of Research and Development
Phase
Phase 2
Overall status
Terminated
Start date
April 16, 2018
Completion date
March 31, 2021
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c